Literature DB >> 28012951

Apomorphine and levodopa in Parkinson's disease: Two revolutionary drugs from the 1950's.

Atbin Djamshidian1, Werner Poewe2.   

Abstract

This article reviews the history of apomorphine and levodopa, which were both discovered in the 1950's and have revolutionized treatment paradigms of Parkinson's disease. Although the discovery of levodopa is a prime example of successful translation of basic neuroscience into clinical routine, the history of apomorphine was based on less solid evidence. Despite this, both drugs are, more than 6 decades after the first clinical experiments, still the two most efficacious medications to treat patients with Parkinson's disease. New and promising delivery strategies for both levodopa and apomorphine are currently under investigation to further improve clinical responses.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apomorphine; History; Levodopa

Mesh:

Substances:

Year:  2016        PMID: 28012951     DOI: 10.1016/j.parkreldis.2016.12.004

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  4 in total

1.  The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias.

Authors:  Vishakh Iyer; Kala Venkiteswaran; Sandip Savaliya; Christopher A Lieu; Erin Handly; Timothy P Gilmour; Allen R Kunselman; Thyagarajan Subramanian
Journal:  Neurobiol Dis       Date:  2021-08-27       Impact factor: 5.996

2.  Molecular docking investigation of the amantadine binding to the enzymes upregulated or downregulated in Parkinson's disease.

Authors:  Mihaela Ileana Ionescu
Journal:  ADMET DMPK       Date:  2020-06-15

3.  5-Amino-3-methyl-Isoxazole-4-carboxylic Acid as a Novel Unnatural Amino Acid in the Solid Phase Synthesis of α/β-Mixed Peptides.

Authors:  Urszula Bąchor; Agnieszka Lizak; Remigiusz Bąchor; Marcin Mączyński
Journal:  Molecules       Date:  2022-08-31       Impact factor: 4.927

Review 4.  Parkinson's disease, dopaminergic drugs and the plant world.

Authors:  Peter Kempster; Andrew Ma
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.